Senior Analyst

About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Overview of Role: Reporting to the Director of SEC Reporting, the Senior Analyst will be an integral member of the Accounting team. This role will be focused on assisting with SEC reporting and month-end close activities. Role and Responsibilities: Assist with the preparation of supporting schedules for form 10-Q, 10-K, and proxy Perform tie out of form 10-K and 10-Q Assist with tracking and recording clinical trial and research-related expenses, including vendor accruals and study-related costs Prepare and post journal entries, including accruals and other standard closing entries Assist with internal and external auditor requests Participate in process improvements, financial system implementations and/or enhancements Assist with ad hoc projects as needed All other duties as assigned Experience, Education and Specialized Knowledge and Skills: Minimum bachelor's degree in accounting Minimum 4+ years of experience in accounting Results-oriented, strong organizational skills, and time management skills with ability to multi-task A team player willing to step in and help with other areas of accounting Excellent analytical, interpersonal, verbal, and written communication skills Superb analytical, strategic, and critical thinking skills, with impeccable attention to detail, and strong prioritization and problem-solving skills Demonstrated ability to operate in a fast-paced environment Attention to detail, accuracy and confidentiality Excellent organizational, management, analytical & decision-making skills An ability to work well cross functionally and across geographies Impeccable integrity and a strong work ethic This is the pay for this position Pay Transparency $117,000 — $130,000 USD Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position m…